Quince Therapeutics【QNCX】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

1.66

買値

1.40

売値

2.45

出来高

185,014

1.65 日の範囲 1.79

0.5116 52 週間の範囲 2.45

時価総額

73.043M

前日終値

1.72

始値

1.77

時刻

1.66

最終取引時間

財務取引量

US$ 311,418

VWAP

1.6832

平均取引量 (3 か月)

527,722

発行済株式数

44,001,643

配当利回り

PER

-2.31

1 株当たり利益 (EPS)

-0.71

歳入

純利益

-31.39M

Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. The company's Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug ... Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. The company's Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug Encapsulation, or AIDE, technology platform, which is a novel drug/device combination that uses an automated process designed to encapsulate a drug into the patient's own red blood cells. 詳細を表示

セクター

Biological Pds,ex Diagnstics

業界

Biological Pds,ex Diagnstics

ウェブサイト

quincetx.com

本社

Wilmington, Delaware, USA

設立

Quince Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker QNCX. The last closing price for Quince Therapeutics was US$1.72. Over the last year, Quince Therapeutics shares have traded in a share price range of US$ 0.5116 to US$ 2.45.

Quince Therapeutics currently has 44,001,643 shares in issue. The market capitalisation of Quince Therapeutics is US$75.68 million. Quince Therapeutics has a price to earnings ratio (PE ratio) of -2.31.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.24	-12.6315789474	1.9	1.97	1.655	174373	1.75268047	CS
4	-0.1067	-6.03950868852	1.7667	2.0397	1.65	138757	1.81698405	CS
12	0.62	59.6153846154	1.04	2.45	0.9691	527722	1.54645378	CS
26	0.918	123.71967655	0.742	2.45	0.5116	371216	1.28938249	CS
52	0.34	25.7575757576	1.32	2.45	0.5116	230085	1.23371833	CS
156	-8.59	-83.8048780488	10.25	10.58	0.5116	455563	2.05931832	CS
260	-61.63	-97.3771527888	63.29	121.98	0.5116	458027	13.20174181	CS

QNCX - Frequently Asked Questions (FAQ)

What is the current Quince Therapeutics share price?

The current share price of Quince Therapeutics is US$ 1.66

How many Quince Therapeutics shares are in issue?

Quince Therapeutics has 44,001,643 shares in issue

What is the market cap of Quince Therapeutics?

The market capitalisation of Quince Therapeutics is USD 75.68M

What is the 1 year trading range for Quince Therapeutics share price?

Quince Therapeutics has traded in the range of US$ 0.5116 to US$ 2.45 during the past year

What is the PE ratio of Quince Therapeutics?

The price to earnings ratio of Quince Therapeutics is -2.31

What is the reporting currency for Quince Therapeutics?

Quince Therapeutics reports financial results in USD

What is the latest annual profit for Quince Therapeutics?

The latest annual profit of Quince Therapeutics is USD -31.39M

What is the registered address of Quince Therapeutics?

The registered address for Quince Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Quince Therapeutics website address?

The website address for Quince Therapeutics is quincetx.com

Which industry sector does Quince Therapeutics operate in?

Quince Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
BTCTBTC Digital Ltd	US$ 8.2697 (73.73%)	61.45M
BDMDBaird Medical Investment Holdings Ltd	US$ 8.80 (62.36%)	18.63M
CRKNCrown Electrokinetics Corporation	US$ 0.1235 (54.96%)	764.86M
NUKKNukkleus Inc	US$ 29.97 (45.98%)	19.09M
GSITGSI Technology	US$ 3.97 (44.36%)	87.7M
DOGZDogness International Corporation	US$ 18.23 (-58.77%)	740.45k
ORKTOrangeKloud Technology Inc	US$ 3.02 (-24.88%)	21.08M
PMAXPowell Max Ltd	US$ 0.6364 (-23.31%)	4.17M
LGCBLinkage Global Inc	US$ 0.2876 (-22.27%)	890.66k
YYAIConnexa Sports Technologies Inc	US$ 0.8299 (-20.20%)	602.48k
CRKNCrown Electrokinetics Corporation	US$ 0.1235 (54.96%)	764.86M
GCTKGlucoTrack Inc	US$ 0.0852 (15.45%)	465.22M
RIMEAlgorhythm Holdings Inc	US$ 0.0406 (-4.02%)	387.23M
TGLTreasure Global Inc	US$ 0.2459 (14.75%)	267.1M
NVDANVIDIA Corporation	US$ 137.71 (3.10%)	201.4M